Hightide Therapeutics Inc (HK:2511)

:2511

2511

Hightide Therapeutics Inc

RESEARCH TOOLSreports

Want to see HK:2511 full AI Analyst Report?

Compare Hightide Therapeutics Inc (2511) vs. Competitors

1 Followers

Comparison Results

2511

Hightide Therapeutics Inc

HK$3.05

HK$2.12B

-2.75

60.00%

1 Buy

0 Hold

0 Sell

Moderate Buy

CANbridge Pharmaceuticals Inc.

HK$2.52

HK$1.30B

―

1410.34%

―

Mabpharm Limited

HK$0.50

HK$1.98B

8.68

9.09%

―

SinoMab Bioscience Ltd.

HK$1.39

HK$1.93B

-7.60

-6.67%

―

Transcenta Holding Limited

HK$2.25

HK$948.36M

-3.97

71.77%

―

Cutia Therapeutics

HK$4.59

HK$1.68B

-3.75

-25.45%

1 Buy

0 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

2511 vs 2487

xxxxxxxxxxxxx

Performance Comparison

HK:2511

Hightide Therapeutics Inc

4.16

1.83

78.54%

HK:1228

CANbridge Pharmaceuticals Inc.

2.19

2.05

1464.29%

HK:2181

Mabpharm Limited

0.48

0.04

9.09%

HK:3681

SinoMab Bioscience Ltd.

1.40

0.11

8.53%

HK:6628

Transcenta Holding Limited

2.13

0.93

77.50%

HK:2487

Cutia Therapeutics

4.60

-2.05

-30.83%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >